首页> 外文期刊>American Journal of PharmTech Research >In vitro Comparative study of Venlafaxine Hydrochloride Sustained Release Formulation using different Lipidic Matrices Prepared by Melt Granulation Technique.
【24h】

In vitro Comparative study of Venlafaxine Hydrochloride Sustained Release Formulation using different Lipidic Matrices Prepared by Melt Granulation Technique.

机译:使用熔体造粒技术制备的不同脂质基质的盐酸文拉法辛缓释制剂的体外比较研究。

获取原文
获取外文期刊封面目录资料

摘要

  ABSTRACT The objective of this study was to investigate hydrogenated vegetable oil (Lubritab) and hydrogenated castor oil (HCO) as potential lipophilic binders in melt granulation process for the preparation of sustained release matrices of venlafaxine hydrochloride, a highly water soluble drug. The effect of concentration, type of polymer and method of preparation (direct compression of physical mixtures and melt granulation technique) were studied. Granules prepared by melt granulation method were evaluated for micromeritic properties, FT-IR, DSC, XRD and SEM. The compressed tablets were subjected to thickness, hardness, friability, mass variation test, drug content and in vitro release studies. The result of dissolution study showed that formulations containing drug: HCO (1:3 m/m) retarded drug release more than those containing drug: Lubritab (1:3 m/m) ratio. In conclusion, melt granulation technique was found to be more appropriate in retarding the release compared to compression of physical mixtures of drug and lipophilic binder. The study showed that HCO and Lubritab are the appropriate meltable binders that can be utilized as matrix-forming agent to sustained the release of highly water soluble drugs. Keywords: sustained release, melt granulation, hydrogenated castor oil, hydrogenated vegetable oil
机译:摘要本研究的目的是研究熔融制粒过程中作为潜在亲脂性粘合剂的氢化植物油(Lubritab)和氢化蓖麻油(HCO),用于制备盐酸文拉法辛(一种高度水溶性的药物)的缓释基质。研究了浓度,聚合物类型和制备方法(物理混合物的直接压缩和熔融制粒技术)的影响。评价了通过熔融造粒法制备的颗粒的微链性能,FT-IR,DSC,XRD和SEM。对压制的片剂进行厚度,硬度,脆性,质量变化测试,药物含量和体外释放研究。溶出度研究的结果表明,含有药物:HCO(1:3 m / m)的制剂比含有药物:Lubritab(1:3 m / m)的制剂更能延迟药物释放。总之,与压缩药物和亲脂性粘合剂的物理混合物相比,发现熔融制粒技术在延迟释放方面更合适。研究表明,HCO和Lubritab是合适的可熔融粘合剂,可用作基质形成剂来维持高度水溶性药物的释放。关键词:缓释,熔融造粒,氢化蓖麻油,氢化植物油

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号